J. Gille et al., RETINOIC ACID INHIBITS THE REGULATED EXPRESSION OF VASCULAR CELL-ADHESION MOLECULE-1 BY CULTURED DERMAL MICROVASCULAR ENDOTHELIAL-CELLS, The Journal of clinical investigation, 99(3), 1997, pp. 492-500
The regulated expression of cell adhesion molecules (CAM) on endotheli
al cells is central to the pathogenesis of various inflammatory proces
ses. Retinoic acid and synthetic derivatives have been demonstrated to
exert antiinflammatory effects in cutaneous diseases. To determine mo
des of retinoid action in the modulation of inflammatory responses, we
explored effects of all-trans-retinoic acid (t-RA) on the TNF alpha-i
nduced expression of vascular cell adhesion molecule-1 (VCAM-1), inter
cellular adhesion molecule-1 (ICAM-1), and E-selectin in cultured huma
n dermal microvascular endothelial cells. Pretreatment with t-RA speci
fically prevented TNF alpha-induced VCAM-1 expression, but not ICAM-1
and E-selectin induction, t-RA significantly reduced VCAM-1-dependent
T cell binding to TNF-alpha-treated human dermal microvascular endothe
lial cells as well. This differential modulation of TNF alpha-induced
CAM expression by t-RA was reflected at steady state mRNA levels and i
n nuclear run-on studies. In transcriptional activation studies, the T
NF alpha-mediated activation of the human VCAM-1 promoter was inhibite
d after t-RA treatment, while the ICAM-1 promoter activation was unaff
ected, indicating that the selective inhibition of CAM expression is r
egulated in part at the level of gene transcription. Furthermore, the
transcriptional inhibition by t-RA. appears to be mediated by its effe
cts upon the activation of NF-kappa B-dependent complex formation. Ana
lysis of protein-DNA binding assays revealed marked inhibition of spec
ific NF-kappa E-dependent binding to the tandem NF-kappa B sites of th
e VCAM-1 promoter, but not to the functional NF-kappa B moth of the IC
AM-1 promoter, The specific inhibition of cytokine-mediated VCAM-1 gen
e expression in vitro may provide a potential basis by which retinoids
exert their biological effects at sites of inflammation in vivo.